EV450 Anti-Human CD20 Antibody[BCA/B20]

The EV450 Anti-Human CD20 Antibody [BCA/B20] is a highly effective and reliable product designed for the specific targeting of CD20 antigen in human cells. This antibody is meticulously developed using advanced biotechnology techniques, ensuring its exceptional quality and performance.

With its exceptional specificity and affinity, the EV450 Anti-Human CD20 Antibody [BCA/B20] offers a valuable tool for various research applications, including immunohistochemistry, flow cytometry, and western blotting. Its ability to specifically bind to CD20 antigen enables accurate identification and analysis of CD20-expressing cells, facilitating comprehensive investigations in the field of immunology and oncology.

The EV450 Anti-Human CD20 Antibody [BCA/B20] exhibits outstanding sensitivity and minimal cross-reactivity, guaranteeing precise and reliable results. Its robust performance and consistent performance make it an ideal choice for researchers and scientists seeking to explore the role of CD20 in various biological processes and diseases.

Furthermore, this antibody is manufactured in strict compliance with the highest quality standards, ensuring batch-to-batch consistency and reproducibility. Its formulation is optimized for long-term stability, allowing for convenient storage and reliable usage over an extended period.

In summary, the EV450 Anti-Human CD20 Antibody [BCA/B20] is a cutting-edge product that offers exceptional specificity, sensitivity, and reliability for the precise targeting and analysis of CD20 antigen in human cells. Its superior performance and stringent quality control make it an indispensable tool for researchers and scientists in the fields of immunology and oncology.